Learn More
Invitrogen™ VIPR1 Polyclonal Antibody

Description
PA3-113 detects VPAC1 Receptor in human samples. PA3-113 has been successfully used in Western blot, immunocytochemistry and immunohistochemistry (paraffin) procedures. By Western blot, this antibody detects an ~55-70 kDa protein representing VPAC1 Receptor in human samples. In immunohistochemistry, VPAC1 Receptor immunoreactivity is predominantly localized at the level of the plasma membrane. PA3-113 immunizing peptide corresponds to amino acid residues 438-457 from human VPAC1 Receptor.
Specifications
Specifications
| Antigen | VIPR1 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Whole serum with 0.05% sodium azide |
| Gene | VIPR1 |
| Gene Accession No. | P32241, P97751 |
| Gene Alias | AV071699; HVR1; II; Pacap receptor; PACAP type II receptor; PACAP-R2; PACAP-R-2; pituitary adenylate cyclase activating polypeptide receptor, type II; pituitary adenylate cyclase-activating polypeptide type II receptor; Pvr2; RATVASREC; RDC1; type 1 vasoactive intestinal peptide receptor; V1RG; VAPC1; vasoactive intestinal peptide receptor 1; vasoactive intestinal polypeptide receptor 1; Vasopressive intestinal peptide receptor; VASREC; VIP and PACAP receptor 1; VIP receptor 1; VIP receptor subtype 1; VIP receptor, type I; VIP1 receptor; VIPR; Vipr1; VIP-R1; VIP-R-1; VIRG; VPAC1; VPAC1 receptor; VPAC1R; VPCAP1R |
| Gene Symbols | VIPR1 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.